# FASENRA

NDC: 0310-1745
Generic name: Benralizumab
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20240405

FDA application: BLA761070

## Active ingredients

- BENRALIZUMAB: 10 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-1745"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-1745
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da6aca1a-19ed-44a4-abb7-696c7d58b784